Summary
Cardinal Health, Inc. (CAH) filed an 8-K on January 30, 2020, disclosing a voluntary field action for select surgical procedure packs, building on a prior voluntary recall of certain surgical gowns initiated in January 2020. These actions are expected to result in a pre-tax charge of $96 million for the quarter ending December 31, 2019. This charge primarily covers inventory write-offs and remediation costs, such as product replacement, and will be excluded from the company's non-GAAP financial results. The company acknowledges that the ultimate loss could differ materially from this accrual due to the unpredictable nature of loss contingencies.
Key Highlights
- 1Cardinal Health is initiating a voluntary field action for select surgical procedure packs.
- 2This action follows a previous voluntary recall of certain surgical gowns announced in January 2020.
- 3A pre-tax charge of $96 million is expected to be recorded for the three months ended December 31, 2019, to cover costs associated with these recalls and field actions.
- 4The charge includes inventory write-offs and remediation expenses like product replacement.
- 5This $96 million charge will be excluded from Cardinal Health's non-GAAP financial results.
- 6The company warns that actual losses may differ materially from the current accrual, highlighting the inherent unpredictability of loss contingencies.
- 7Potential negative impacts beyond the immediate charge include government investigations, regulatory actions, customer claims, and reputational harm.
Frequently Asked Questions
Cardinal Health expects to record a pre-tax charge of $96 million for the quarter ending December 31, 2019, to cover estimated costs related to the voluntary field action and the recall of surgical gowns. This charge includes inventory write-offs and remediation costs, such as replacing recalled products.
No, the $96 million charge, along with any future increases or adjustments related to these recalls, will be excluded from Cardinal Health's non-GAAP financial results. Investors should refer to the company's non-GAAP reporting for earnings excluding these specific items.
Cardinal Health acknowledges several potential risks, including government investigations and enforcement actions from regulators like the FDA, potential product seizures, further recalls, suspension of operating licenses, customer and patient claims leading to lawsuits, significant reputational damage, and loss of customers and sales. The company also notes that actual loss amounts could differ materially from the current accrual.
The filing mentions voluntary field actions for 'select surgical procedure packs' and a prior voluntary recall of 'certain surgical gowns.' Specific product names or catalog numbers are not detailed in this 8-K filing but are likely available in the referenced news release (Exhibit 99.1).